![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1349281 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC35B2 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1615831 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC35B2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1615831 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of SLC35B2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1615831 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC35B2 mRNA | CTD | PMID:20702594, PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC35B2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1615831 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC35B2 mRNA | CTD | PMID:25270620 | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | ISO | RGD:1615831 | 6480464 | 2 more ... | CTD | PMID:20702594 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of SLC35B2 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of SLC35B2 mRNA | CTD | PMID:21346803 | acrolein | multiple interactions | ISO | RGD:1349281 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC35B2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC35B2 mRNA | CTD | PMID:32699268 | alpha-pinene | multiple interactions | ISO | RGD:1349281 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC35B2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC35B2 mRNA | CTD | PMID:32699268 | aristolochic acid A | decreases expression | ISO | RGD:1349281 | 6480464 | aristolochic acid I results in decreased expression of SLC35B2 mRNA, aristolochic acid I results in decreased expression of SLC35B2 protein | CTD | PMID:33212167 | Aroclor 1254 | increases expression | ISO | RGD:1615831 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of SLC35B2 mRNA | CTD | PMID:23650126 | benzo[a]pyrene | increases methylation | ISO | RGD:1349281 | 6480464 | Benzo(a)pyrene results in increased methylation of SLC35B2 3' UTR | CTD | PMID:27901495 | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC35B2 mRNA | CTD | PMID:18164116 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SLC35B2 mRNA | CTD | PMID:25181051 more ... | cadmium atom | multiple interactions | ISO | RGD:1349281 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC35B2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1349281 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC35B2 mRNA | CTD | PMID:35301059 | CGP 52608 | multiple interactions | ISO | RGD:1349281 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLC35B2 gene] | CTD | PMID:28238834 | chloropicrin | affects expression | ISO | RGD:1349281 | 6480464 | chloropicrin affects the expression of SLC35B2 mRNA | CTD | PMID:26352163 | clofibrate | decreases expression | ISO | RGD:1615831 | 6480464 | Clofibrate results in decreased expression of SLC35B2 mRNA | CTD | PMID:23811191 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of SLC35B2 mRNA | CTD | PMID:20187946 | copper(II) sulfate | decreases expression | ISO | RGD:1349281 | 6480464 | Copper Sulfate results in decreased expression of SLC35B2 mRNA | CTD | PMID:19549813 | coumarin | decreases phosphorylation | ISO | RGD:1349281 | 6480464 | coumarin results in decreased phosphorylation of SLC35B2 protein | CTD | PMID:35688186 | cyclosporin A | decreases expression | ISO | RGD:1349281 | 6480464 | Cyclosporine results in decreased expression of SLC35B2 mRNA | CTD | PMID:24907557, PMID:25562108 | epoxiconazole | decreases expression | ISO | RGD:1615831 | 6480464 | epoxiconazole results in decreased expression of SLC35B2 mRNA | CTD | PMID:35436446 | ethanol | affects expression | ISO | RGD:1615831 | 6480464 | Ethanol affects the expression of SLC35B2 mRNA | CTD | PMID:30319688 | fenthion | decreases expression | ISO | RGD:1615831 | 6480464 | Fenthion results in decreased expression of SLC35B2 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | RGD:1615831 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC35B2 mRNA | CTD | PMID:22206623 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SLC35B2 mRNA | CTD | PMID:22061828 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SLC35B2 mRNA | CTD | PMID:33387578 | hypochlorous acid | decreases expression | ISO | RGD:1615831 | 6480464 | Hypochlorous Acid results in decreased expression of SLC35B2 mRNA | CTD | PMID:19376150 | ivermectin | decreases expression | ISO | RGD:1349281 | 6480464 | Ivermectin results in decreased expression of SLC35B2 protein | CTD | PMID:32959892 | methamphetamine | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC35B2 mRNA | CTD | PMID:19564919 | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of SLC35B2 mRNA | CTD | PMID:19564919 | methidathion | decreases expression | ISO | RGD:1615831 | 6480464 | methidathion results in decreased expression of SLC35B2 mRNA | CTD | PMID:34813904 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC35B2 mRNA | CTD | PMID:18164116 | oxycodone | decreases expression | EXP | | 6480464 | Oxycodone results in decreased expression of SLC35B2 mRNA | CTD | PMID:23439660 | ozone | multiple interactions | ISO | RGD:1349281 | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC35B2 mRNA more ... | CTD | PMID:32699268 | paracetamol | affects expression | ISO | RGD:1615831 | 6480464 | Acetaminophen affects the expression of SLC35B2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SLC35B2 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | RGD:1349281 | 6480464 | Acetaminophen results in decreased expression of SLC35B2 mRNA | CTD | PMID:21420995 | paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of SLC35B2 mRNA | CTD | PMID:16854511 | perfluorooctanoic acid | decreases expression | ISO | RGD:1349281 | 6480464 | perfluorooctanoic acid results in decreased expression of SLC35B2 protein | CTD | PMID:26879310 | potassium chromate | multiple interactions | ISO | RGD:1349281 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC35B2 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:1349281 | 6480464 | potassium chromate(VI) results in decreased expression of SLC35B2 mRNA | CTD | PMID:22079256 | SCH 23390 | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC35B2 mRNA | CTD | PMID:19564919 | sodium arsenate | increases expression | ISO | RGD:1615831 | 6480464 | sodium arsenate results in increased expression of SLC35B2 mRNA | CTD | PMID:30953684 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SLC35B2 mRNA | CTD | PMID:19281266 | streptozocin | multiple interactions | EXP | | 6480464 | cobaltiprotoporphyrin inhibits the reaction [Streptozocin results in decreased expression of SLC35B2 protein], tin mesoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Streptozocin results in decreased expression of SLC35B2 protein]] | CTD | PMID:16595661 | streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of SLC35B2 protein | CTD | PMID:16595661 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SLC35B2 mRNA | CTD | PMID:34492290 | valproic acid | affects expression | ISO | RGD:1349281 | 6480464 | Valproic Acid affects the expression of SLC35B2 mRNA | CTD | PMID:25979313 | |